ADCT
ADC Therapeutic N (ADCT)
NYSE
$1.61+$0.10 (+6.36%)
Price as of Nov 11, 2026 7:42 PM EST
  • $213.2M
    Market Cap
  • -61.96%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
NANTAHALA CAPITAL MANAGEMENT, LLC
9.65%
12.3M
+6.7M (+54.59%)
Jun 30, 2026
REDMILE GROUP, LLC
9.03%
11.5M
-3.9M (-34.21%)
Jun 30, 2026
TCG CROSSOVER MANAGEMENT, LLC
8.92%
11.4M
0 (0.00%)
Jun 30, 2026
PROSIGHT MANAGEMENT, LP
6.13%
7.8M
-475,251 (-6.07%)
Jun 30, 2026
BLACKROCK, INC.
5.50%
7.0M
+769,346 (+10.96%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
3.93%
5.0M
+612,723 (+12.23%)
Dec 31, 2024
AIGH CAPITAL MANAGEMENT LLC
3.39%
4.3M
+4.3M (+100.00%)
Sep 30, 2026

Current Ownership Distribution

  • Institutions1.0B (85.93%)
  • Mutual Funds133.4M (11.40%)
  • Insiders31.2M (2.67%)
  • Other0 (0.00%)

Insider Transactions

  • 2.67% (31.2M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
MALLIK AMEET
Chief Executive Officer
Award
Jun 30, 2026
$0.00
675,000
$0.00
2.1M
Zaki Mohamed
Chief Medical Officer
Award
Jun 30, 2026
$0.00
213,900
$0.00
896,317
GRAHAM PETER J
Chief Legal Officer
Award
Jun 30, 2026
$0.00
221,100
$0.00
841,640